Skip to Main Content

Author Details

Yasheng Zhu
Changhai Hospital, Naval Military Medical University
2014
36
21
PMIDPaper TitleJournal TitlePublished Year
37070788Robotic-assisted versus laparoscopic radical prostatectomy for prostate cancer: the first separate systematic review and meta-analysis of randomised controlled trials and non-randomised studies.Int J Surg2023
37538150Cell-free DNA in the management of prostate cancer: Current status and future prospective.Asian J Urol2023
37497216E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies.Front Immunol2023
37468683Comprehensive analysis of the prognosis and immune infiltration of TMC family members in renal clear cell carcinoma.Sci Rep2023
37039264Knockdown of kinesin family member 4A inhibits cell proliferation, migration, and invasion while promoting apoptosis of urothelial bladder carcinoma cells.Cancer Med2023
34740924Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy.Clin Cancer Res2022
35755294Development and clinical advancement of small molecules for <i>ex vivo</i> expansion of hematopoietic stem cell.Acta Pharm Sin B2022
34875521Discovery of novel and orally bioavailable CDK 4/6 inhibitors with high kinome selectivity, low toxicity and long-acting stability for the treatment of multiple myeloma.Eur J Med Chem2022
35233061OTUD6A promotes prostate tumorigenesis via deubiquitinating Brg1 and AR.Commun Biol2022
35194188ERK1/2 inhibits Cullin 3/SPOP-mediated PrLZ ubiquitination and degradation to modulate prostate cancer progression.Cell Death Differ2022
33420488Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression.Nat Cell Biol2021
33785037Circulating exosomal mRNA profiling identifies novel signatures for the detection of prostate cancer.Mol Cancer2021
34353330SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions.Mol Cancer2021
31107971The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.Int J Cancer2020
31857702Deubiquitinating enzyme USP33 restrains docetaxel-induced apoptosis via stabilising the phosphatase DUSP1 in prostate cancer.Cell Death Differ2020
32592689Novel Long Non-coding RNA lncAMPC Promotes Metastasis and Immunosuppression in Prostate Cancer by Stimulating LIF/LIFR Expression.Mol Ther2020
30595538SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression.Dev Cell2019
31771591Prostate Cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly.Mol Cancer2019
31270456Author Correction: Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.Nature2019
31555390Heterogeneity of PTEN and PPAR-γ in cancer and their prognostic application to bladder cancer.Exp Ther Med2019
31534967Discovery and Validation of Serum MicroRNAs as Early Diagnostic Biomarkers for Prostate Cancer in Chinese Population.Biomed Res Int2019
30809318Prostatic Acid Phosphatase (PAP) Predicts Prostate Cancer Progress in a Population-Based Study: The Renewal of PAP?Dis Markers2019
28927585Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression.Eur Urol2018
29468960The Discovery of Antibacterial Natural Compound Based on Peptide Deformylase.Comb Chem High Throughput Screen2018
29160310Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.Nature2018
26780868Prostate cancer antigen 3 moderately improves diagnostic accuracy in Chinese patients undergoing first prostate biopsy.Asian J Androl2017
28805822Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.Nat Med2017
27023495Structure-Based Drug Design of Small Molecule Peptide Deformylase Inhibitors to Treat Cancer.Molecules2016
27428963Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs.Int J Mol Sci2016
26808578A feed-forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression.Cancer Lett2016
25597901A novel urinary long non-coding RNA transcript improves diagnostic accuracy in patients undergoing prostate biopsy.Prostate2015
26485765Identification of specific DNA methylation sites on the Y-chromosome as biomarker in prostate cancer.Oncotarget2015
26344096Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation.Mol Cell2015
26527005SPOP E3 Ubiquitin Ligase Adaptor Promotes Cellular Senescence by Degrading the SENP7 deSUMOylase.Cell Rep2015
26008593Clinical utility of a novel urine-based gene fusion TTTY15-USP9Y in predicting prostate biopsy outcome.Urol Oncol2015
25526029Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer.Oncotarget2014
  • 1 - 36 of 36

Recommended Authors

Jiayu Liang
institute of urology
Career Start Year 2016
Number of shared co-authors 1
Yaser Gamallat
Cumming School of Medicine, University of Calgary
Career Start Year 2016
Number of shared co-authors 1
Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 1
Yuliang Wang
The Chinese University of Hong Kong
Career Start Year 2014
Number of shared co-authors 0
Zitong Zhao
School of Pharmacy, Wannan Medical College
Career Start Year 2012
Number of shared co-authors 2
Jiaxing Lin
Peking University People's Hospital
Career Start Year 2012
Number of shared co-authors 0
Haiyang Guo
the Second Hospital, Cheeloo College of Medicine, Shandong University
Career Start Year 2011
Number of shared co-authors 15
Yusuke Goto
Chiba University Graduate School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Lu Ji
West China Hospital, Sichuan University
Career Start Year 2010
Number of shared co-authors 1
Mohammed Alshalalfa
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 7
Sungyong You
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 4
Anne Haegert
University of British Columbia
Career Start Year 2008
Number of shared co-authors 10
John R Prensner
University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 6
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year 2007
Number of shared co-authors 2
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 7
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 14
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 6
Fan Mo
Institute of Stem Cell and Regeneration, Chinese Academy of Sciences
Career Start Year 2004
Number of shared co-authors 9
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 4
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 2003
Number of shared co-authors 5
Lin Qi
Xiangya Hospital of Central South University
Career Start Year 2003
Number of shared co-authors 0
Tarek A Bismar
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Career Start Year 2002
Number of shared co-authors 5
Seok-Soo Byun
Seoul National University Bundang Hospital
Career Start Year 2002
Number of shared co-authors 0
Ladan Fazli
University of British Columbia
Career Start Year 2002
Number of shared co-authors 13
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 2
Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
Career Start Year 1994
Number of shared co-authors 2
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 10
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 1
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 2

Collaborators

Shancheng Ren
Shanghai Changzheng Hospital
Co-authored papers 22
Fubo Wang
Center for Genomic and Personalized Medicine, Guangxi Medical University
Co-authored papers 12
Yu-Tian Xiao
Shanghai Changhai Hospital, Naval Medical University
Co-authored papers 3
Bo Zhang
Novel Bioinformatics Co.
Co-authored papers 2
Yongwei Yu
Changhai Hospital
Co-authored papers 2
Mingyao Liu
The Institute of Biomedical Sciences, East China Normal University
Co-authored papers 2
Sujun Chen
Princess Margaret Cancer Center/University Health Network
Co-authored papers 2
Yue Yang
Institute of Cancer Prevention and Treatment, Harbin Medical University
Co-authored papers 2
Jiaoti Huang
Duke University School of Medicine
Co-authored papers 2
Yao Li
Fudan University
Co-authored papers 2
Zhengfang Yi
The Institute of Biomedical Sciences, East China Normal University
Co-authored papers 2
Fei Liu
Shanghai Changhai Hospital
Co-authored papers 2
Yuzhuo Wang
University of British Columbia
Co-authored papers 1
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 1
Na Zhang
Obstetrics and Gynecology Hospital of Fudan University
Co-authored papers 1
Jun Wang
Zhongnan Hospital of Wuhan University
Co-authored papers 1
Weidong Chen
Novel Bioinformatics Co.
Co-authored papers 1
Dai Chen
University of Washington
Co-authored papers 1
Colin C Collins
University of British Columbia
Co-authored papers 1
Shida Zhu
Co-authored papers 1
Jianhua Wang
Anhui University of Science & Technology
Co-authored papers 1
Stanislav V Volik
University of British Columbia
Co-authored papers 1
Robert H Bell
University of British Columbia
Co-authored papers 1
Huanming Yang
Experimental Research Center, China Academy of Chinese Medical Sciences
Co-authored papers 1
Helen Loo Yau
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Qinghua Guo
Novel Bioinformatics Co.
Co-authored papers 1
Zhou Jiang
China University of Geosciences
Co-authored papers 1
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 1
Release 1.2